Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

123 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Cytogenetic Study of Ocular Melanoma

NCT00344799

Conditions: Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +12 more
Locations: Jules Stein Eye Institute Los Angeles, California, United States

View Trial Details

Completed

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

NCT01430416

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Dana Farber Cancer Institute DFCI - Brookline Boston, Massachusetts, United States

Memorial Sloan Kettering MSKCC 4 New York, United States

Novartis Investigative Site Paris, France

Novartis Investigative Site Leiden, Netherlands

View Trial Details

Completed

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

NCT02308553

Conditions: Cutaneous Malignant Melanoma, Melanoma, Melanoma, Cutaneous Malignant, +11 more
Locations: University Hospital Essen Essen, North Rhine-Westphalia, Germany

Elbeklinikum Buxtehude Buxtehude, Germany

SRH Wald-Klinikum Gera Gera, Germany

National Centre for Tumour Diseases (NCT) Heidelberg, Germany

View Trial Details

Completed

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

NCT04577742

Conditions: 106 Ruthenium Plaque Brachytherapy, Eye Diseases, Eye Neoplasms, +12 more
Locations: University of Naples "Federico II" Naples, Italy

View Trial Details

Completed

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

NCT02771340

Conditions: Choroid Diseases, Choroid Neoplasm, Choroid Neoplasms, +14 more
Locations: San Francisco, California, United States

Denver, Colorado, United States

Leawood, Kansas, United States

Boston, Massachusetts, United States

View Trial Details

Completed

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

NCT02363283

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View all 25 locations

View Trial Details

Completed

Clinical and Histopathologic Characteristics of BAP1 Mutations

NCT01773655

Conditions: Adenocarcinoma, Adenoma, Carcinoma, +40 more
Locations: Memorial Sloan Kettering Westchester Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

NCT01413191

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Eye Diseases, +17 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

NCT01100528

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Eye Diseases, +15 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

NCT01200238

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Melanoma

Melanoma trial results

Related conditions